Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase Ia First-in-Human Study to Evaluate the Single Intravenous Administration of ISH0613 in Healthy Subjects

NCT07516639 is registered in ClinicalTrials.gov with SUNHO（China）BioPharmaceutical CO., Ltd. as lead sponsor.

NCT NCT07516639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase Ia First-in-Human Study to Evaluate the Single Intravenous Administration of ISH0613 in Healthy Subjects
Lead sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
December 31, 2026
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects (hs), sle (systemic lupus)